Zantac Study Finding Increased Risk of Cancer Results in Supplemental Expert Reports Being Filed in MDL
Research published last month highlight the link between various cancers and Zantac, including liver, lung, gastric and pancreatic cancers.
Research published last month highlight the link between various cancers and Zantac, including liver, lung, gastric and pancreatic cancers.
Zantac cancers supported in the federal courts are limited to bladder, esophageal, gastric, liver and pancreatic. Thousands of other lawsuits are being filed in state courts involving breast, kidney, colorectal, prostate, and other cancers.
Zantac Daubert hearings will be held by the judge to determine whether proposed expert witness testimony about the risk of specific cancers from Zantac is sufficiently sound to present to a jury.
Shortly before trial was set to begin in Illinois state court, a Zantac cancer settlement was reached with generic drug makers, and the plaintiff dismissed their lawsuit against name-brand manufacturers
Approaching trial dates and analyst estimates that Zantac settlement payouts may reach $45 billion caused investor stock selloff this week
Court has pushed back the start of first California Zantac trials, with cases set to go before juries starting in February, May, August and October 2023
Motions were filed in advance of hearings scheduled for September 2022, at which time the Court will weigh the reliability of expert testimony on the link between Zantac and cancer.
Both drug and medical device recalls hit record highs in the early months of this year, posing serious health and safety risks for Americans
MDL Judge will decide at a series of Daubert hearings which expert testimony about the link between Zantac and cancer will be admissible at trial
Judge approved a four month stay in a Belviq lawsuit, while parties explore global settlement negotiations to resolve cancer claims over the recalled diet drug